RAMM Pharma Corp. RAMM
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -214.65% | 63.07% | 89.39% | -1,254.79% | -160.93% |
| Total Depreciation and Amortization | 21.42% | -14.63% | 2.46% | -22.50% | -29.72% |
| Total Amortization of Deferred Charges | 0.00% | -20.00% | 25.00% | -- | -- |
| Total Other Non-Cash Items | -595.77% | 57.57% | -107.49% | 71,619.23% | 98.92% |
| Change in Net Operating Assets | 424.13% | -189.78% | -61.68% | 1,173.30% | -24.20% |
| Cash from Operations | 110.77% | -184.37% | -301.49% | 65.35% | 47.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -161.23% | -83.12% | 46.70% | 635.15% | -93.40% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -161.23% | -83.12% | 46.70% | 635.15% | -93.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 9.09% | -9.36% | -0.59% | 64.88% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 95.12% | -- |
| Cash from Financing | -11.29% | 8.15% | -6.30% | 30.60% | 46.33% |
| Foreign Exchange rate Adjustments | -97.22% | 140.45% | -909.09% | 178.57% | 92.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.13% | -582.51% | -33.82% | 225.83% | -184.33% |